Literature DB >> 17031204

Liver involvement in childhood histiocytic syndromes.

S L Guthery1, J E Heubi.   

Abstract

The histiocytic syndromes of childhood are disorders of the reticuloendothelial system with variable clinical manifestations. Included among them are Langerhans cell histiocytosis and hemophagocytic lymphohistiocytosis. This discussion will be restricted to these two disorders. Liver disease in these conditions is common. Langerhans cell histiocytosis is characterized by the abnormal clonal proliferation of the macrophage-derived Langerhans cell. Liver involvement at diagnosis has management and prognostic significance. In a subgroup of patients, sclerosing cholangitis develops, which may lead to end-stage liver disease requiring liver transplantation. Hemophagocytic lymphohistiocytosis is a disease of abnormally activated macrophages that can involve multiple organ systems, including the liver. Differentiation between this disorder and other causes of pediatric liver disease is critical, because treatment strategies include chemotherapy, immunosuppression, and frequently bone marrow transplantation.

Entities:  

Year:  2001        PMID: 17031204     DOI: 10.1097/00001574-200109000-00013

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  5 in total

1.  Disseminated langerhans cell histiocytosis presenting as cholestatic jaundice.

Authors:  Rohit Kapoor; Anthony M Loizides; Soumya Sachdeva; Premila Paul
Journal:  J Clin Diagn Res       Date:  2015-02-01

2.  Adult Langerhans cell histiocytosis and sclerosing cholangitis: a case report and review of the literature.

Authors:  Ibrahim Hatemi; Birol Baysal; Hakan Senturk; Kemal Behzatoglu; Erol Rustu Bozkurt; Gulsen Ozbay
Journal:  Hepatol Int       Date:  2010-08-04       Impact factor: 6.047

3.  The clinical and laboratory evaluation of familial hemophagocytic lymphohistiocytosis and the importance of hepatic and spinal cord involvement: a single center experience.

Authors:  Burcin Beken; Selin Aytac; Gunay Balta; Baris Kuskonmaz; Duygu Uckan; Sule Unal; Mualla Cetin; Fatma Gumruk
Journal:  Haematologica       Date:  2017-11-16       Impact factor: 9.941

4.  The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis.

Authors:  Giusi Prencipe; Claudia Bracaglia; Ivan Caiello; Antonia Pascarella; Paola Francalanci; Manuela Pardeo; Alessandra Meneghel; Giorgia Martini; Marianna N Rossi; Antonella Insalaco; Giulia Marucci; Valerio Nobili; Marco Spada; Francesco Zulian; Fabrizio De Benedetti
Journal:  PLoS One       Date:  2019-12-17       Impact factor: 3.240

5.  The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis.

Authors:  Guangli Yin; Changfeng Man; Shengen Liao; Hongxia Qiu
Journal:  Mediators Inflamm       Date:  2020-12-05       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.